Empire Life Investments’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$257K Sell
1,755
-286
-14% -$51.8K 0.01% 112
2026
Q1
$296K Sell
2,041
-324
-14% -$52.7K 0.02% 109
2025
Q4
$461K Sell
2,365
-477
-17% -$114K 0.03% 107
2025
Q3
$799K Hold
2,842
0.05% 103
2025
Q2
$621K Buy
+2,842
New +$459K 0.04% 107
2017
Q4
Sell
-508,314
Closed -$24.6M 105
2017
Q3
$24.6M Buy
508,314
+9,268
+2% +$461K 1.99% 15
2017
Q2
$25M Buy
499,046
+1,323
+0.3% +$60.3K 2.18% 12
2017
Q1
$18M Sell
497,723
-84,872
-15% -$3.53M 1.75% 16
2016
Q4
$23.1M Buy
+582,595
New +$22.8M 1.88% 18

Other funds holding ORCL

Empire Life Investments's ORCL Position: Q2 2026 in Review

Empire Life Investments reduced its Oracle (ORCL) stake by 14% in Q2 2026, selling an estimated $51.8K and leaving 1,755 shares worth $257K. The position accounts for 0.01% of the portfolio, ranked #112.

Empire Life Investments first reported a position in ORCL in Q4 2016 and has held it in 9 quarters since. The position peaked at $25M in Q2 2017. 3,507 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Empire Life Investments held 1,755 shares of Oracle worth $257K as of Q2 2026.
  • Empire Life Investments sold 286 Oracle shares in Q2 2026, an estimated $51.8K.
  • Oracle made up 0.01% of Empire Life Investments's portfolio in Q2 2026, its #112 holding.
  • Empire Life Investments first reported a position in Oracle in Q4 2016 and has held it in 9 quarters since.
  • Empire Life Investments's Oracle position peaked at $25M in Q2 2017.
  • 3,507 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Empire Life Investments's 13F filing for Q2 2026, filed 24 Jul 2026.